Loading...
NPI 1720378524 · Franklin Park, IL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Star Lab, Inc is a clinical medical laboratory provider located in Franklin Park, Illinois. This profile covers 132 Medicare and 60 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Star Lab, Inc |
| Address | 9213 Parklane Ave |
| City | Franklin Park |
| State | IL |
| ZIP | 60131 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | April 13, 2011 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $5.4M |
| Medicaid | $5.2M |
STAR LAB, INC’s billing mix shows a hybrid service model combining mobile/homebound specimen collection with high-volume phlebotomy and molecular infectious disease testing. Medicare billing is dominated by travel allowances for home/nursing specimen collection (P9603, $2.3M, 45.8% of Medicare revenue) alongside large-volume venipuncture (36415, $388.9K, 7.9% Medicare), while both Medicare and Medicaid include substantial SARS-CoV-2 molecular testing (e.g., U0004 appears on both payer lists). This pattern indicates operational capacity for both decentralized specimen pickup and centralized laboratory processing.
Medicare revenue is highly concentrated: the precomputed top-3 Medicare codes account for 63.2% of the provider’s total Medicare revenue, led by P9603, U0004, and 36415. That level of concentration implies material sensitivity of Medicare revenue to changes in policies or demand for travel-allowance payments and COVID-related testing, since a handful of codes drive the majority of receipts.
Medicaid revenue is even more concentrated in a small set of codes: the top-3 Medicaid codes account for 76.7% of total Medicaid revenue, with U0004 alone representing $3M (59.7% of Medicaid revenue). This indicates the provider’s Medicaid business is largely driven by high-throughput SARS-CoV-2 molecular testing and associated collection fees (U0004, U0005, G2023), suggesting dependence on infectious-disease testing volume for state-payor revenue.
Comparing payer scale, STAR LAB reports $5.4M in total Medicare revenue and $5.2M in total Medicaid revenue, a near-parity government payer mix rather than single-payer concentration. This balance means shifts in either program’s coverage or reimbursement for key tests could materially affect overall revenue, but the provider is not effectively single-payer dependent.
On competitive standing, STAR LAB is a dominant outlier on several measures: P9603 ranks #3 of 267 nationally (99th percentile; extreme outlier) showing exceptional national volume for travel specimen-collection allowance, and 36415 ranks #74 of 86467 (100th percentile; extreme outlier) reflecting very high national phlebotomy volume. For COVID testing, U0004 ranks #13 of 259 nationally in Medicare (95th percentile; notably above typical) and #3 of 48 in-state for Medicaid (96th percentile; typical), indicating strong regional market presence for SARS-CoV-2 molecular testing.
While several routine chemistry and endocrine panels appear on the lists, their standing is mixed: codes like 82306 ($188.4K; Medicare) and 80053 ($172.6K; Medicare) are described as "typical, unremarkable" volumes despite being nontrivial revenue contributors, whereas hematology/collection codes such as 85025 ($165.8K; Medicare) sit at the 100th percentile and are noted as "notably above typical." This suggests the lab performs high absolute volumes of basic panels and CBCs but only a few codes are unusually concentrated relative to peers.
State-level specialty strengths are visible beyond COVID testing: for example, 87184 (culture susceptibility) ranks #9 of 290 nationally (97th percentile; notably above typical) and #2 of 35 in-state for Medicaid (97th percentile; notably above typical state volume), indicating stronger-than-typical capacity in microbiology susceptibility testing. These high rankings in antimicrobial susceptibility are consistent with a lab that supports both diagnostic culture work and broad outpatient collection.
STAR LAB’s NPI tenure (enumerated 2011-04-13, ~15 years ago) indicates an established provider relationship window with payers and referral sources. That longevity, combined with unusually high ranks on travel-collection and phlebotomy codes, supports a view of an operationally mature clinical lab focused on specimen collection logistics and high-throughput testing rather than a newly formed entrant.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
132 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 2,252,640 | $1 | $2.3M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 6,350 | $70 | $469.6K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 48,610 | $10 | $388.9K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 6,500 | $30 | $188.4K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 17,260 | $10 | $172.6K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 7,700 | $20 | $169.4K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 20,730 | $10 | $165.8K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 9,560 | $20 | $153K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,840 | $20 | $134.2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 4,660 | $30 | $116.5K |
Showing 1–10 of 132
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 132 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
132 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 86328 | 6 | 10 | 60 | $40 | $909K |
| U0004 | 5 | 20 | 530 | $70 | $383.5K |
| P9603 | 1 | 40 | 35,960 | $1 | $232.2K |
| G2023 | 12 | 90 | 400 | $20 | $96.5K |
| U0005 | 13 | 100 | 270 | $20 | $86.3K |
| 82652 | 4 | 10 | 1,390 | $40 | $69.6K |
| 87799 | 5 | 10 | 340 | $40 | $46.3K |
| 84300 | 5 | 10 | 450 | $1 | $43.9K |
| 80307 | 53 | 70 | 120 | $60 | $27.2K |
| 86480 | 2 | 20 | 40 | $60 | $23.1K |
Showing 1–10 of 132
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
60 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 46,860 | $60 | $3M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 21,670 | $20 | $455K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 21,180 | $20 | $402.5K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 14,550 | $20 | $247.3K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 16,490 | $10 | $131.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 9,270 | $10 | $129.8K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 22,530 | $10 | $112.6K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 7,140 | $10 | $71.4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,310 | $40 | $56.3K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 9,140 | $10 | $45.7K |
Showing 1–10 of 60
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
60 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 3 | 50 | 710 | $70 | $1.2M |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen… | 12 | 20 | 470 | $20 | $351.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 265 | 280 | 1,120 | $30 | $218.9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 24 | 210 | 680 | $20 | $206.4K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 133 | 170 | 150 | $200 | $190.9K |
| 86328 | The lab analyst performs a single–step immunoassay to qualitatively or semiquantitatively evaluate the patient’s specimen for antibodies to the severe acute respiratory syndrome coronavirus 2… | 19 | 30 | 110 | $40 | $95K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 21 | 400 | 550 | $20 | $90.8K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 112 | 740 | 960 | $10 | $75.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 60 | 530 | 840 | $10 | $73.9K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 3 | 20 | 1,750 | $10 | $66.6K |
Showing 1–10 of 60
Other providers in the same ZIP code as Star Lab, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Leyden Family Service & Mental Health Center | IL | Mental Health Clinic/Center (Including Community Mental Health Center) | $0 | $8.1M |
| Village Of Franklin Park | IL | Ambulance | $122.7K | $6.8M |
| Asterlation Inc | IL | Clinical Medical Laboratory | $0 | $4.9M |
| Leyden Family Service & Mental Health Center | IL | Mental Health Clinic/Center (Including Community Mental Health Center) | $0 | $4.1M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.